臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51255486 線上人數 : 836 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pin nan"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 21-30 / 39 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國立成功大學	2021-07	Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis	Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu
國立成功大學	2021-06	Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss	Wu;I-Chin;Liu;Wen-Chun;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學	2021-03	Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan	Chiu;Hung-Chih;Chiu;Yen-Cheng;Yang;Er-Hsiang;Chang;Ting-Tsung;Chien;Shih-Chieh;Wu;I-Chin;Wu;Chun-Hsien;Cheng;Pin-Nan
國立成功大學	2021-01	Persistent augmentation of central arterial stiffness following viral clearance by direct-acting antivirals in chronic hepatitis C	Chen;Ju-Yi;Cheng;Pin-Nan;Chiu;Yen-Cheng;Chiu;Hung-Chih;Tsai;Wei-Chuan;Tsai;Liang-Miin
國立成功大學	2020-07	Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry	Wu;Hsin-Yi;Pan;Yu-Yi;Kopylov;Arthur, T.;Zgoda;Victor;Ma;Mi-Chia;Wang;Ching-Hsun;Su;Wu-Chou;Lai;Wu-Wei;Cheng;Pin-Nan;Liao;Pao-Chi
國立成功大學	2020-05	Limited drug-drug interaction of elbasvir/grazoprevir for chronic hepatitis C	Liu;Chun-Jen;Tseng;Kuo-Chih;Lo;Ching-Chu;Tseng;I-Hao;Cheng;Pin-Nan
國立成功大學	2020-04	Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients	Liu;Wen-Chun;Wu;I-Chin;Chiu;Yen-Cheng;Tseng;Kuo-Chih;Chen;Chi-Yi;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學	2020-03	Real-world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan	Chen;Jyh-Jou;Lee;Pei-Lun;Chiu;Hung-Chih;Tung;Hung-Da;Chiu;Yen-Cheng;Cheng;Pin-Nan
國立成功大學	2019-11	Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy	Lin;Tien-Ching;Liu;Wen-Chun;Hsu;Yu-Hsiang;Lin;Jia-Jhen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin
國立成功大學	2019-05	Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan	Cheng;Pin-Nan;Chiu;Yen-Cheng;Chien;Shih-Chieh;Chiu;Hung-Chih

顯示項目 21-30 / 39 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目